Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (91-100 of 420) with videos related to

Pageof 42
Sort By:
Diagnostic Microbiology and Infectious Disease|August 26, 2006
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)Ronald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|December 11, 2007
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centersRodrigo E Mendes, Helio S Sader, Lalitagauri Deshpande, et al.
Current Opinion in Pharmacology|November 15, 2017
The application of in vitro surveillance data for antibacterial dose selectionRobert K Flamm, Helio S Sader, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organismsSudha Pottumarthy, Lalitagauri M Deshpande, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2019
Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. HospitalsMariana Castanheira, Timothy B Doyle, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 23, 2022
Antimicrobial activity of high-dose cefepime-tazobactam (WCK 4282) against a large collection of gram-negative organisms collected worldwide in 2018 and 2019Helio S Sader, Cecilia G Carvalhaes, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2021
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infectionsHelio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
BMC Infectious Diseases|November 5, 2024
Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacteralesHelio S Sader, John H Kimbrough, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Activity of Plazomicin Tested against <i>Enterobacterales</i> Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among AminoglycosidesMariana Castanheira, Helio S Sader, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2005
Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importanceThomas R Fritsche, Helio S Sader, Roy Cleeland, et al.
Pageof 42

Showing results (91-100 of 420) with videos related to

Sort By:
Pageof 42
Diagnostic Microbiology and Infectious Disease|August 26, 2006
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)Ronald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|December 11, 2007
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centersRodrigo E Mendes, Helio S Sader, Lalitagauri Deshpande, et al.
Current Opinion in Pharmacology|November 15, 2017
The application of in vitro surveillance data for antibacterial dose selectionRobert K Flamm, Helio S Sader, Mariana Castanheira, et al.
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organismsSudha Pottumarthy, Lalitagauri M Deshpande, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2019
Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. HospitalsMariana Castanheira, Timothy B Doyle, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 23, 2022
Antimicrobial activity of high-dose cefepime-tazobactam (WCK 4282) against a large collection of gram-negative organisms collected worldwide in 2018 and 2019Helio S Sader, Cecilia G Carvalhaes, Rodrigo E Mendes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2021
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infectionsHelio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
BMC Infectious Diseases|November 5, 2024
Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacteralesHelio S Sader, John H Kimbrough, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Activity of Plazomicin Tested against <i>Enterobacterales</i> Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among AminoglycosidesMariana Castanheira, Helio S Sader, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2005
Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importanceThomas R Fritsche, Helio S Sader, Roy Cleeland, et al.
Pageof 42